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ABSTRACT 
To analyze and characterize the chemical composition of the different crude extracts from the rhizome of Curcuma aeruginosa Roxb a medicinal 
plant. The air-dried rhizomes were powdered and subjected to Soxhlet extraction using solvent n-hexane and Supercritical fluid extraction. Then, 
each of the extracts was further subjected to gas chromatography-mass spectrometry. Qualitative determination of the different biologically 
active compounds from crude extracts of C aeruginosa Roxb using gas chromatography–mass spectrometry revealed different types of high and 
low molecular weight chemical entities with varying quantities present in each of the extracts. These chemical compounds are considered 
biologically and pharmacologically important. Furthermore, the two different extracts SCF and n-hexane possess unique physicochemical 
characteristics. The two extracts possess major bioactive compounds that were identified and characterized spectroscopically. Thus, 
identification of different biologically active compounds in the extracts of C aeruginosa Roxb warrants further biological and pharmacological 
studies. 
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INTRODUCTION 
Plants play a significant role in the prevention and treatment 
of diseases and can even prevent and reduce the adverse 
effects of conventional treatments 1. They can be a source of 
chemical compounds of biological and pharmacological 
importance. History reveals that plants are sources of 
successful drugs, and will continuously be important for 
screening of new lead compounds 2. An essential part in the 
investigation of a plant is the identification of the biologically 
active compounds present in plant leading to further 
biological and pharmacological studies 3–5. The search for 
new plant-derived chemicals should thus be a priority in 
current and future efforts toward sustainable conservation 
and rational utilization of biodiversity 6. The family 
Zingiberaceae comprises advanced monocot plants and is 
characterized by aromatic, non‑tuberous and tuberous 
rhizomes, which have tremendous ethno medicinal 
properties.7,8 Curcuma aeruginosa was commonly known as 
‘Black turmeric’ is a perennial underutilized herb of the 
family Zingiberaceae. It usually grows well in moist 
deciduous forests.9 The plant has a characteristic rhizome 
flesh of bluish black color with a pungent smell and hot bitter 
taste, because of the presence of essential oil rich in camphor 
and starch. The rhizome is traditionally used in the 
treatment of hemorrhoids, leprosy, asthma, cancer, fever, 
wounds, vomiting, menstrual disorder, anthelmintic, 
aphrodisiac, gonorrheal discharges, and inflammation.10,11. 
The rhizome of C. aeruginosa is a promising source of 
potential anti‑oxidants.12 It is employed for making various 
cosmetic items and for sprains and bruises.13 
Anti‑androgenic effect of sesquiterpenes isolated from the 
rhizomes of C. aeruginosa had been reported.14 Due to its 
high medicinal value and indiscriminate harvest from the 
wild, the natural population has come down and according to 
International Union for Conservation of Nature (IUCN) 
report, the plant is in the critically endangered category.15 
This paper mostly highlighted on the analysis and 
identification of bioactive compounds present in the plant 
extracts through GC-MS. 
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MATERIAL AND METHODS  
Plant material:  Plant material was collected in February 
2015 from Waynad district of Kerala, India. Taxonomic 
identification of the plants was carried out by Dr. S John 
Britto, Director at the Rapinat Herbarium, St. Joseph’s 
College, Tiruchirappalli, Tamilnadu, India. Voucher 
specimens (RHT 68570) are submitted at the Rapinat 
Herbarium. Fresh rhizomes of Black turmeric (Curcuma 
aeruginosa) was collected and cultivated in Vadakkencherry 
Holy Family garden.  
Preparation of Plant Extract 
The collected rhizomes were dried under the room 
temperature and powdered with a mechanical grinder and 
stored in air tight container. 
Super Critical Fluid Extraction 
SFE was carried out on the extraction system (model HA220-
50-06, Nantong, China) which consists of a 5 L volume 
extractor, an HA220-50-06 controller, two syringe pumps 
(model 100 DX, Jiangsu, China), and a CO2 cylinder. The 
operation pressure and temperature could reach up to 80 
MPa and 45ºC. The extraction pressure of the system was 
adjusted by a pressure regulator and the temperature was 
controlled by a thermostatic water bath. The parameters, 
namely, extraction pressure (P), temperature (T), dynamic 
extraction time (t), and flow rate of CO2 (F), were studied 
and optimized. 
For each extraction, about 1.0 kg of the prepared plant 
material was loaded into the extractor. Dense liquid 16 CO2 is 
then pumped through a cylinder containing the material to 
be extracted. The extract-laden liquid is then pumped into a 
separation chamber where the extract is separated from the 
gas and the gas is recovered for re-use. The extracted 
substances were collected at the bottom of the separators. 
Soxhlet method of hexane extraction 
The 20 g of dried powder was subjected to Soxhlet extraction 
using hexane. The solvent (150 ml of hexane) is added to a 
round bottom flask (250ml volume), which is attached to a 
Soxhlet extractor and condenser on an isomantle. The 
rhizome powder is loaded into the thimble, which is placed 
inside the Soxhlet extractor. The sidearm is lagged with glass 
wool. The solvent is heated using the isomantle and will 
begin to evaporate, moving through the apparatus to the 
condenser. The condensate then drips into the reservoir 
containing the thimble. Once the level of the solvent reaches 
the siphon it pours back into the flask and the cycle begins 
again. The process runs for two days at 60ºC. 
GC–MS analysis 
GC-MS analysis was performed on a Shimadzu (Tokyo, 
Japan) Make GCMS-TQ8030  with nonpolar  Rxi 5Sil MS 
capillary column, full scan mode, injector mode-splitless, 
quadra pole mass selective detector(MSD), injection 
temperature 250ºC, GC-MS interface temperature 250ºC, the 
injection volume was 1μl. Helium was employed as the 
carrier gas, at a pressure of 57.5KPa; ﬂow rate was 1ml/min. 
Mass spectra were detected at 70eV. Temperature 
programming was set as follows: column temperature was 
started from 60ºC (held for2 min) and linearly increased by 
5ºC/min to 200ºC (held for 2min); after that, it was 
increased by 3ºC/min to 220ºC (held for 1 min); further, it 
was increased by 6ºC/min. to 250ºC (held for 7min). Total 
GC running time was 51.67 min. The components of the oil 
were identified by comparison of their mass spectra with 
those of the spectrometer database using NIST library 
(Shimadzu). The identifications were confirmed by 
comparison of the fragmentation pattern and their retention 
indices with those reported in the literature. 
RESULTS AND DISCUSSION 
Bioactive compounds present in the SFE and Hexane 
extracts, since various parameters potentially affect the 
extraction process, the optimization of the experimental 
conditions is a critical step in developing an SFE method. 
Based on the previous knowledge of SFE, the extraction 
pressure, temperature, the dynamic extraction time and flow 
rate of CO2 are usually considered as the most important 
factors of SFE. The optimal conditions for extraction of C 
aeruginosa by SFE were 40 MPa of pressure, 50ºC of 
temperature, 1.5 h dynamic extraction time and 40 
L/Hour (20Hz) flow rate of CO2. Figure 1 and 2 depicts a GC-
MS chromatograph of C aeruginosa obtained by SFE and 
Soxhlet method. The identification of the compounds was 
done by NIST as well as of compound, quality, retention 
times, molecular weight (MW) and relative content with 
those from literature data 17. The GC–MS analysis of 
compounds from C aeruginosa extracts was performed using 
a Rxi 5 Sil MS capillary column. In Table 1 (Fig:1)was 
reported the GC–MS data and the compounds identified in 
the extracts of C aeruginosa by SFE at the set of 40 MPa of 
pressure, 50ºC of temperature, 1.5 h dynamic extraction time 
and 40 L/Hour (20Hz) flow rate of CO2. Based on abundance, 
the major compounds present in the SCF extract were 5 
.beta.- Guaia-7(11),10(14)-dien-8.alpha.-ol,5,8-epoxy-,(+)-
(27.09%),7H-2,4a-Methanonaphthalen-7one, 1,2,3,4,5,6-
hexahydro-1,1,5,5-tetramethyl-,(2S,4aR)-(-)-(6.31%), 
Boldenone(5.89%), (2E)-2-(4Methoxybenzylidene) Cyclo 
hexanone (4.2%), 17.alfa.,21.beta.-28,30 Bisnorhopane 
(3.81%), 5.beta.-Guaia-7(11),10(14)-dien-8.α-ol,5,8-epoxy-
,(+)-(3.28%), Nootkaton-11,12-epoxide(3%), Bis(2-
ethylhexyl) phthalate(2.85%), (+)-2Bornanone (2.08%),2-
(1-(Beta-d-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-
7-oxo-7H furo(3,2-g)chromene, (R)-(2.6%), Tetracyclo 
[5.4.3.0(7,11)]tetradeca-2,5,10-trione, 1,4,6,14-tetramethyl-
4-vinyl-(1.84%), Naphthalene, deca hydro-1,4a-dimethyl-2-
methylene-(1.81%), 1,5,9-Cyclo dodecatriene, 1,5,9-
trimethyl-(1.81%),2H-Cyclohepta [b]furan-2-one,6-[1-
(acetyloxy)-3-oxobutyl]-3,3a,4,7,8,8a-hexahydro-7-methyl-
3-methylene-(1.81%),as-Indacen-4(1H)-one,decahydro-
,(3a.alpha.,5a. beta., 8a.beta.,8b.beta.)-(1.42%),2,4-DIISO 
PROPENYL-1-METHYL-1-VINYLCYCLO HEXANE (1.35%), 
1,2-Dimethyl-5-nitroadamantane(1.31%),  Caryophyllene 
(1.29%), 5-Isoborneol(1.03%). 
Table 2 (Fig; 2) depicts that biologically active chemical 
compound of n-hexane extract from C aeruginosa Roxb. 
rhizome the major compounds found in this were 5.beta.-
Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)-
(13.34%), 17-HYDROXYANDROSTA-1,4-DIEN-3-ONE(8.5%), 
5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)-
(8.47%), Naphthalene, decahydro-1,4a-dimethyl-2-
methylene-(7.37%),(2E)-2-(4-Methoxybenzylidene) Cyclo 
hexanone(6.94%), Cycloprop[e]indene-1a,2(1H)-dicarbox 
aldehyde, 3a,4,5,6,6a,6b-hexahydro-5,5,6b-trimethyl-, 
(1a.alpha.,3a.beta.,6a.beta.,6b.alpha(5.72%), 5,8-Dihydroxy-
4a-methyl-4,4a,4b,5,6,7,8,8a,9,10-decahydro-2(3H)-
phenanthrenone(4.77%), n-Hexadecanoic acid (4.02%), 
Cycloprop[e]indene-1a,2(1H)-dicarboxaldehyde, 3a,4,5,6, 
6a,6b-hexahydro-5,5,6b-trimethyl-, (1a.alpha.,3a. beta.,6a. 
beta.,6b.alpha(3.86%), Valerenal (3.56%), 5-Isopropenyl-
3,6-Dimethyl-6-Vinyl-4,5,6,7-Tetrahydro-1-Benzofuran 
(2.72%), 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-
epoxy-, (+)-(1.93%), (3aRS,4SR,6aRS,2'Z)-Hexahydro-3-
methylidene-4-(pent-2'-enyl)-2H-cyclopenta[b]furan-2-
one(1.91%), Cyclopropane, 1,1-Dimethyl-2-(2-Methyl -3-
Buten-2-YL)- (1.83%), Thunbergol(1.83%), (-)-Isolongifolol, 
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pentafluoropropionate(1.68%), 7-Tetradecenal, (Z)-( 
1.59%), Bufa-20,22-dienolide, 14,15-epoxy-3,5,16-
trihydroxy-, (3.beta.,5.beta.,15.beta.,16.beta.)-( 1.44%), 1H-
Cycloprop[e]azulene, 1a,2,3,5,6,7,7a,7b-octahydro-1,1,4,7-
tetramethyl-, (+)-(1.41%), 6-Isopropenyl-4,8a-dimethyl-
1,2,3,5,6,7,8,8a-octahydro-naphthalen-2-ol(1.22%), 17-
Hydroxyandrosta-1,4-DIEN-3-ONE(1.18%), 3,7-Cyclodeca 
dien-1-one, 3,7-dimethyl-10-(1-methylethylidene)-, (E,E)-( 
1.16%), 1,1,7-TRIMETHYL-4-METHYLENEDECAHYDRO-1H-
CYCLOPROPA[E]AZULEN-7-OL(1.07%), Cycloprop[e]indene-
1a,2(1H)-dicarboxaldehyde, 3a,4,5,6,6a,6b-hexahydro-
5,5,6b-trimethyl (1a.alpha.3a.beta.6a. beta., 6b. apha (1.3%) , 
Isospathulenol(1.1%). 
DISCUSSION 
The usage of plants or herbs for medicinal purposes relies on 
their phytochemical composition that exhibits some 
interesting and specific biological activities. Different 
phytochemicals identified in the present study have been 
found to possess a wide range of biological activities. It has 
long been reported that Zingiberaceae families contained a 
number of phytochemicals such as terpenoids, flavonoids, 
phenypropanoids and sesquiterpenes which exhibited anti-
tumor activities 18, 19. GC–MS analysis of the SCF and Hexane 
extract revealed the presence of various bioactive 
compounds. Direct solvent extraction using SCF revealed the 
occurrence of 68 compounds whereas Hexane allowed the 
extraction of 52 compounds respectively. All the major 
compounds from different extracts are biologically active 
molecules. They are considered to be a part of plants’ 
defense systems, and as such have been included in a large 
group of protective molecules found in plants named 
‘phytoanticipins’ or ‘phytoprotectants’20-22. There are several 
reports in the chemical composition of the essential oil from 
the rhizome of Curcuma species 23-25, Monoterpene and 
sesquiterpene hydrocarbons represented the most common 
chemical groups found in the essential oils from the 
rhizomes of the investigated Curcuma species 26. Several 
phytochemicals identified in the rhizome of C. aeruginosa in 
the present study have previously been reported by other 
researchers. These included compounds such as 
germacrone27,28, cycloisolongifolene 8,9-dehydro-9-formyl, 
velleral and camphor29, 1,8-cineole, pinene30, curzerene and 
elemene31. However, most of the above mentioned 
compounds were detected in the essential oil of C. 
aeruginosa rhizome. While comparing the GCMS results of  
two extracts three compounds present in both extracts 
namely,5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-
epoxy, (+)- (30.37% SCF and 23.74% Hexane) (2E)-2-
(4METHOXYBENZYLIDENE) CYCLOHEXANONE (4.20% and 
6.94%) Naphthalene, decahydro-1,4a-dimethyl-2-
methylene-(1.81% and7.37%) respectively in different 
concentrations. These major compounds have cytotoxic, 
antioxidant, antitumor antiangiogenic32,33 cytotoxicity34,35 
cholesterol‐lowering activity36 use in agrochemicals, 
pharmaceuticals and perfumes37. It has been reported that 
terpenes have antibacterial activity because of their 
bacteriostatic and bactericidal effects 38. 
It was concluded that SCF and hexane extract of rhizome of 
Curcuma aeruginosa possess various potent bioactive 
compounds and is recommended as a plant of 
phytopharmaceutical importance. Further studies are 
needed to explore the potential compounds responsible for 
the biological activity from Curcuma aeruginosa for 
application in drug delivery, nutritional or pharmaceutical 
fields.
 
 
Figure 1: A typical chromatogram of the bioactive compounds present in SCF extract. 
 
Table 1: Biologically active chemical compounds of SCF extract from C aeruginosa Roxb. 
Sl. 
No.                                                                                                                                                                RT    
 Peak 
area (%) Name of the compound
Molecular 
formula MW (g/mol) 
1 7.601 0.07 3-Carene C10H16 136.24 
2 8.15 0.23 D-Limonene C10H16  136.24 
3 8.261 0.25 Eucalyptol C10H18O  154.25 
4 11.505 2.08 (+)-2-Bornanone C10H16O   152.24 
5 12.002 1.03 Isoborneol C10H18O  154.25 
6 12.251 0.5 1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-OL C10H17ClO  188.70 
7 12.902 0.52 3-Cyclohexene-1-methanol, .alpha.,.alpha.,4-trimethyl- C12H20O2  196.29 
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8 15.411 0.82 Bicyclo[2.2.1]heptan-2-ol, 1,7,7-trimethyl-, acetate, exo- C19H24O2   284.40 
9 16.728 0.09 .delta.-Elemene C15H24   204.36 
10 18.185 1.35 2,4-DIISOPROPENYL-1-METHYL-1-VINYLCYCLOHEXANE C15H24  204.36 
11 18.99 1.29 Caryophyllene C15H24  204.36 
12 19.204 0.08 .gamma.-Elemene C15H24  204.36 
13 19.715 0.09 
1H-Cycloprop[e]azulene, decahydro-1,1,7-trimethyl-4-
methylene-, (1aR,4aS,7R,7aR,7bS)-(-)- 
C15H24 204.36 
14 19.89 0.12 .alpha.-Humulene C15H24  204.36 
15 20.332 0.17 
2-Isopropenyl-4a,8-dimethyl-1,2,3,4,4a,5,6,7-
octahydronaphthalene 
C15H24   204.36 
16 20.74 0.86 .beta.-Selinene C15H24 204.36 
17 20.834 0.48 
5-ISOPROPENYL-3,6-DIMETHYL-6-VINYL-4,5,6,7-
TETRAHYDRO-1-BENZOFURAN 
C15H20O 216.32 
18 20.916 0.73 
2-ISOPROPENYL-4A,8-DIMETHYL-1,2,3,4,4A,5,6,8A-
OCTAHYDRONAPHTHALENE 
C15H24 204.36 
19 21.146 0.13 .beta.-Bisabolene C15H24 204.36 
20 21.314 0.07 
1-ISOPROPYL-7-METHYL-4-METHYLENE-1,2,3,4,4A,5,6,8A-
OCTAHYDRONAPHTHALENE 
C15H24   204.36 
21 21.413 0.11 4-epi-cubedol C15H26O 222.37 
22 22.803 0.19 
Spiro[4H-cycloprop[e]azulene-4,2'-oxirane], decahydro-1,1,7-
trimethyl-, [1aR-(1a.alpha.,4.beta.,4a.alpha.,7.alpha.,7a.beta.,7b. 
  
23 23.007 0.49 
(-)-5-Oxatricyclo[8.2.0.0(4,6)]dodecane,,12-trimethyl-9-
methylene-, [1R-(1R*,4R*,6R*,10S*)]- 
C15H24O 220.36 
24 23.163 0.11 
1,1,4,7-TETRAMETHYLDECAHYDRO-1H-
CYCLOPROPA[E]AZULEN-4-OL 
C15H26O 222.37 
25 23.295 0.41 
2-(4a,8-Dimethyl-2,3,4,4a,5,6,7,8-octahydro-2-naphthalenyl)-2-
propanol 
C15H26O 222.37 
26 23.443 5.89 Boldenone C19H26O2 286.42 
27 23.62 0.05 Hexagermane Ge6H16Si  479.99 
28 23.64 0.04 ALLO AROMADENDRENOXID-(1) C15H24 204.36 
29 23.687 0.23 N-(4-HYDROXYPHENYL)-N,N',N'-TRIMETHYLSULFAMIDE C9H14N2O3S 230.28 
30 23.962 3.28 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- C15H22 O2 234.34 
31 24.103 0.94 isospathulenol C15H24O 220.36 
32 24.511 0.4 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- C15H22 O2 234.34 
33 24.789 0.77 
1-Naphthalenol, decahydro-1,4a-dimethyl-7-(1-
methylethylidene)-, [1R-(1.alpha.,4a.beta.,8a.alpha.)]- 
C15H26O  222.37 
34 25.029 0.88 
1H-Cycloprop[e]azulen-7-ol, decahydro-1,1,7-trimethyl-4-
methylene-, [1a (1a.alpha.,4a.alpha.,7.beta.,7a.beta.,7b.alpha.)]- 
C15H24O   220.36 
35 25.308 0.61 (3E)-5-Isopropyliden-6-methyl-3,6,9-decatrien-2-one C14H20O 204.31 
36 25.539 0.77 3,7-Cyclodecadien-1-one, 10-(1-methylethenyl)-, (E,E)- C13H18O  190.29 
37 25.905 0.45 valerenol C15H24O 220.36 
38 26.447 27.09 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- C15 H22 O2 234.15 
39 26.731 1.81 Naphthalene, decahydro-1,4a-dimethyl-2-methylene- C13H22  178.32 
40 26.936 0.92 
5,8-Dihydroxy-4a-methyl-4,4a,4b,5,6,7,8,8a,9,10-decahydro-
2(3H)-phenanthrenone 
C15H22O3 250.34 
41 27.295 0.46 Murolan-3,9(11)-diene-10-peroxy C15H24O2 236.36 
42 27.451 3.81 17.alfa.,21.beta.-28,30-Bisnorhopane C28H48 384.69 
43 27.687 2.16 
5-Azulenemethanol, 1,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.,3,8-
tetramethyl-, [3S-(3.alpha.,5.alpha.,8.alpha.)]- 
C15H26O 
222.37 
 
44 27.763 0.49 1,2,3,4-TETRAKIS(1-METHYLETHYLIDENE)CYCLOBUTANE C16H24 216.37 
45 27.832 0.44 Norethynodrel C20H26O2 298.43 
46 28.615 4.2 (2E)-2-(4-METHOXYBENZYLIDENE)CYCLOHEXANONE C14H16O2 216.28 
47 28.712 1.81 1,5,9-Cyclododecatriene, 1,5,9-trimethyl- C15H24 204.36 
48 28.925 0.49 4-Isopropyl-7,11-dimethyl-3,7,11-cyclotetradecatrienone C19H30O 274.45 
49 29.008 0.87 
7-ISOPROPENYL-1,4-DIMETHYL-1,2,3,4,5,6,7,8-
OCTAHYDROAZULENE 
C15H24  204.36 
50 29.358 0.36 
3-Oxatricyclo[20.8.0.0(7,16)]triaconta-1(22),7(16),9,13,23,29-
hexaene 
C29H42O 406.65 
51 29.681 0.66 
2-[4-methyl-6-(2,6,6-trimethylcyclohex-1-enyl)hexa-1,3,5-
trienyl]cyclohex-1-en-1-carboxaldehyde 
C23H32O 324.51 
52 30.136 0.45 .gamma.-Elemene C15H24  204.36 
53 30.613 0.37 
1,6-Dimethyl-9-(1-methylethylidene)-5,12-
dioxatricyclo[9.1.0.0(4,6)]dodecan-8-one 
C15H22O3 250.34 
54 31.47 0.94 2,10-Dimethyl-4H,8H-benzo[1,2-b : 3,4-b']dipyran-4-one   
55 31.608 3 Nootkaton-11,12-epoxide C15H22O2 234.34 
56 31.709 0.61 
2(3H)-Benzofuranone, 6-ethenylhexahydro-6-methyl-3-
methylene-7-(1-methylethenyl)-, [3aS-
C15H20O2  232.32 
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(3a.alpha.,6.alpha.,7.beta.,7a.beta.)]- 
57 32.086 6.31 
7H-2,4a-Methanonaphthalen-7-one, 1,2,3,4,5,6-hexahydro-
1,1,5,5-tetramethyl-, (2S,4aR)-(-)- 
C15H22O 218.34 
58 32.476 1.11 1-Cyclohexene-1-crotonaldehyde, .alpha.,2,6,6-tetramethyl-   
59 32.911 1.31 1,2-Dimethyl-5-nitroadamantane C12H19NO2  209.29 
60 33.177 1.04 
1,6-Methanonaphthalene, decahydro-1,4,8a-trimethyl-9-
methylene-, (1S,4S,4aS,6R,8aS)-(-)- 
C15H24 204.36 
61 33.425 2.6 
2-(1-(Beta-d-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-
7-oxo-7H-furo(3,2-g)chromene, (R)- 
C20H24O9   408.40 
62 34.117 0.77 
5aH-3a,12-Methano-1H-
cyclopropa[5',6']cyclodeca[1',2':1,5]cyclopenta[1,2-
d][1,3]dioxol-13-one, 1a,2,3,9,12,12a-hexahydro-9-hydr 
C23H32O5 388.50 
63 34.272 0.38 
1,2-Naphthalenedione, 6-hydroxy-3,8-dimethyl-5-(1-
methylethyl)- 
C15H16O3 244.29 
64 34.925 1.42 
as-Indacen-4(1H)-one, decahydro-, 
(3a.alpha.,5a.beta.,8a.beta.,8b.beta.)- 
C12H18O 178.28 
65 35.014 1.84 
Tetracyclo[5.4.3.0(7,11)]tetradeca-2,5,10-trione, 1,4,6,14-
tetramethyl-4-vinyl- 
C20H28O3 316.44 
66 36.793 1.81 
2H-Cyclohepta[b]furan-2-one, 6-[1-(acetyloxy)-3-oxobutyl]-
3,3a,4,7,8,8a-hexahydro-7-methyl-3-methylene- 
C17H22O5  306.36 
67 38.243 0.47 
4,7-Methanofuro[3,2-c]oxacycloundecin-6(4H)-one, 7,8,9,12-
tetrahydro-3,11-dimethyl- 
C15H18O3 246.31 
68 44.93 2.85 Bis(2-ethylhexyl) phthalate C24H38O4 390.56 
 
 
Figure 2: A typical chromatogram of the bioactive compounds present in Hexane extract. 
 
Table 2: Biologically active chemical compounds of Hexane extract from C aeruginosa Roxb. 
Sl. 
No.                                                                                                                                                                RT    
 Peak 
area (%) Name of the compound
Molecular 
formula 
MW 
(g/mol) 
1 18.126 0.59 2,4-DIISOPROPENYL-1-METHYL-1-VINYLCYCLOHEXANE C15H24 204.36 
2 19.147 0.46 
Cyclohexane, 1-ethenyl-1-methyl-2-(1-methylethenyl)-4-(1-
methylethylidene)- 
C15H24 204.36 
3 20.676 0.46 .beta.-Selinene C15H24  204.36 
4 20.813 2.72 
5-ISOPROPENYL-3,6-DIMETHYL-6-VINYL-4,5,6,7-
TETRAHYDRO-1-BENZOFURAN 
C15H20O 216.32 
5 21.845 0.1 
1,5-Cyclodecadiene, 1,5-dimethyl-8-(1-methylethylidene)-, 
(E,E)- 
C15H24  204.36 
6 22.934 0.19 
(-)-5-Oxatricyclo[8.2.0.0(4,6)]dodecane,,12-trimethyl-9-
methylene-, [1R-(1R*,4R*,6R*,10S*)]- 
 
C15H24O 
 
220.36 
7 23.099 0.36 
Azulene, 1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-(1-
methylethenyl)-, [1R-(1.alpha.,3a.beta.,4.alpha.,7.beta.)]- 
C15H24  204.36 
8 23.478 8.5 17-HYDROXYANDROSTA-1,4-DIEN-3-ONE C19H26O2 
286.42 
 
9 23.712 1.18 17-HYDROXYANDROSTA-1,4-DIEN-3-ONE C19H26O3 286.42 
10 23.802 0.24 
6-Isopropenyl-4,8a-dimethyl-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-ol 
C15H24O 220.36 
11 24.058 8.47 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- C15H22 O2 234.34 
12 24.129 1.1 isospathulenol C15H24O 220.36 
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13 24.205 0.29 .gama.-eudesmol C15H26O 222.37 
14 24.373 0.69 (+)-epi-Bicyclosesquiphellandrene C15H24  204.36 
15 24.541 1.93 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- 
  
16 24.769 1.83 Thunbergol C20H34O 290.49 
17 24.977 1.07 
1,1,7-TRIMETHYL-4-METHYLENEDECAHYDRO-1H-
CYCLOPROPA[E]AZULEN-7-OL 
C15H24O 220.36 
18 25.113 0.44 2-Propen-1-ol, 3-(2,6,6-trimethyl-1-cyclohexen-1-yl)- C12H20O 180.29 
19 25.251 0.55 
Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-
methylethylidene)-, (1S-cis)- 
C15H24  204.36 
20 25.503 1.16 
3,7-Cyclodecadien-1-one, 3,7-dimethyl-10-(1-
methylethylidene)-, (E,E)- 
C15H22O 218.34 
21 25.666 0.5 
1,4-Hexadien-3-one, 5-methyl-1-[2,6,6-trimethyl-2,4-
cyclohexadien-1-yl]- 
C16H22O 230.35 
22 25.842 1.22 
6-Isopropenyl-4,8a-dimethyl-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-ol 
C15H24O 220.36 
23 25.973 1.41 
1H-Cycloprop[e]azulene, 1a,2,3,5,6,7,7a,7b-octahydro-1,1,4,7-
tetramethyl-, (+)- 
C15H24 204.36 
24 26.408 13.34 5.beta.-Guaia-7(11),10(14)-dien-8.alpha.-ol, 5,8-epoxy-, (+)- C15H22 O2 234.34 
25 26.714 1.91 
(3aRS,4SR,6aRS,2'Z)-Hexahydro-3-methylidene-4-(pent-2'-
enyl)-2H-cyclopenta[b]furan-2-one   
26 26.934 4.77 
5,8-Dihydroxy-4a-methyl-4,4a,4b,5,6,7,8,8a,9,10-decahydro-
2(3H)-phenanthrenone 
C15H22O3 250.34 
27 27.48 7.37 Naphthalene, decahydro-1,4a-dimethyl-2-methylene- C13H22  178.32 
28 27.693 5.72 
Cycloprop[e]indene-1a,2(1H)-dicarboxaldehyde, 
3a,4,5,6,6a,6b-hexahydro-5,5,6b-trimethyl-, 
(1a.alpha.,3a.beta.,6a.beta.,6b.alpha 
C15H20O2 232.32 
29 27.876 0.87 1,5-epoxysalvial-4(14)-ene C15H24O  220.36 
30 28.13 1.68 (-)-Isolongifolol, pentafluoropropionate C18H25F5O2  368.39 
31 28.611 6.94 (2E)-2-(4-METHOXYBENZYLIDENE)CYCLOHEXANONE C14H16O2   216.28 
32 28.971 3.86 
Cycloprop[e]indene-1a,2(1H)-dicarboxaldehyde, 
3a,4,5,6,6a,6b-hexahydro-5,5,6b-trimethyl-, 
(1a.alpha.,3a.beta.,6a.beta.,6b.alpha 
C15H20O2  232.32 
33 29.287 1.3 
Cycloprop[e]indene-1a,2(1H)-dicarboxaldehyde, 
3a,4,5,6,6a,6b-hexahydro-5,5,6b-trimethyl-, 
(1a.alpha.,3a.beta.,6a.beta.,6b.alpha 
C15H20O2  232.32 
34 29.63 1.83 
CYCLOPROPANE, 1,1-DIMETHYL-2-(2-METHYL-3-BUTEN-2-
YL)-   
35 29.89 1.44 
Bufa-20,22-dienolide, 14,15-epoxy-3,5,16-trihydroxy-, 
(3.beta.,5.beta.,15.beta.,16.beta.)- 
C28H36O8 500.59 
36 30.43 0.85 
3-METHYL-5-(2,6,6-TRIMETHYL-1-CYCLOHEXEN-1-YL)-1-
PENTYN-3-OL 
C15H24O 220.36 
37 31.294 4.02 n-Hexadecanoic acid C16H32O2 256.43 
38 31.59 0.59 
2(3H)-Benzofuranone, 6-ethenylhexahydro-6-methyl-3-
methylene-7-(1-methylethenyl)-, [3aS-
(3a.alpha.,6.alpha.,7.beta.,7a.beta.)]- 
C15H20O2 232.32 
39 31.959 3.56 Valerenal C15H22O 218.34 
40 32.25 0.4 1-Cyclohexene-1-crotonaldehyde, .alpha.,2,6,6-tetramethyl- C14H24O 208.35 
41 32.705 0.43 1,2-Dimethyl-5-nitroadamantane C12H19NO2  209.29 
42 33.188 0.61 
2-(1-(Beta-d-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-
7-oxo-7H-furo(3,2-g)chromene, (R)- 
C20H24O9  408.40 
43 34.736 0.22 
1,4-Methanophthalazine, 1,4,4a,5,6,7,8,8a-octahydro-1,4,9,9-
tetramethyl-, (1.alpha.,4.alpha.,4a.alpha.,8a.alpha.)- 
C13H22N2 206.33 
44 35.639 1.59 7-Tetradecenal, (Z)- C14H26O  210.36 
45 39.391 0.33 Behenic alcohol C22H46O 326.61 
46 41.933 0.1 Hexanedioic acid, bis(2-ethylhexyl) ester C22H42O4  370.57 
47 42.24 0.11 Heneicosane C21H44  296.58 
48 44.114 0.13 1-Heptacosanol C27H56O 396.74 
49 44.274 0.13 Hexacosane C26H54 366.72 
50 44.761 0.21 Bis(2-ethylhexyl) phthalate C24H38O4  390.56 
51 46.184 0.13 Hexacosane C26H54 366.72 
52 48.468 0.1 Hexacosane C26H55 366.72 
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